JP2014500296A5 - - Google Patents

Download PDF

Info

Publication number
JP2014500296A5
JP2014500296A5 JP2013545376A JP2013545376A JP2014500296A5 JP 2014500296 A5 JP2014500296 A5 JP 2014500296A5 JP 2013545376 A JP2013545376 A JP 2013545376A JP 2013545376 A JP2013545376 A JP 2013545376A JP 2014500296 A5 JP2014500296 A5 JP 2014500296A5
Authority
JP
Japan
Prior art keywords
alkyl
independently
alkynyl
cycloalkyl
alkenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013545376A
Other languages
English (en)
Japanese (ja)
Other versions
JP5824068B2 (ja
JP2014500296A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2011/073654 external-priority patent/WO2012085127A1/en
Publication of JP2014500296A publication Critical patent/JP2014500296A/ja
Publication of JP2014500296A5 publication Critical patent/JP2014500296A5/ja
Application granted granted Critical
Publication of JP5824068B2 publication Critical patent/JP5824068B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013545376A 2010-12-21 2011-12-21 セリン/トレオニンキナーゼ阻害剤としての新規トリアゾリルフェニルスルホンアミド Active JP5824068B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP10196274.4 2010-12-21
EP10196274 2010-12-21
EP11181598 2011-09-16
EP11181598.1 2011-09-16
PCT/EP2011/073654 WO2012085127A1 (en) 2010-12-21 2011-12-21 New triazolylphenyl sulfonamides as serine/threonine kinase inhibitors

Publications (3)

Publication Number Publication Date
JP2014500296A JP2014500296A (ja) 2014-01-09
JP2014500296A5 true JP2014500296A5 (enExample) 2015-02-19
JP5824068B2 JP5824068B2 (ja) 2015-11-25

Family

ID=45401080

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013545376A Active JP5824068B2 (ja) 2010-12-21 2011-12-21 セリン/トレオニンキナーゼ阻害剤としての新規トリアゾリルフェニルスルホンアミド

Country Status (5)

Country Link
US (1) US8710055B2 (enExample)
EP (1) EP2655355B1 (enExample)
JP (1) JP5824068B2 (enExample)
AR (1) AR084443A1 (enExample)
WO (1) WO2012085127A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20090837A1 (es) 2007-07-02 2009-07-24 Boehringer Ingelheim Int Nuevos compuestos quimicos
TW201014860A (en) 2008-09-08 2010-04-16 Boehringer Ingelheim Int New chemical compounds
EA201100564A1 (ru) 2008-09-29 2011-12-30 Бёрингер Ингельхайм Интернациональ Гмбх Антипролиферативные соединения
US8569316B2 (en) 2009-02-17 2013-10-29 Boehringer Ingelheim International Gmbh Pyrimido [5,4-D] pyrimidine derivatives for the inhibition of tyrosine kinases
JP5871896B2 (ja) 2010-03-26 2016-03-01 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング B−rafキナーゼインヒビター
WO2011117382A1 (en) 2010-03-26 2011-09-29 Boehringer Ingelheim International Gmbh Pyridyltriazoles
US8710055B2 (en) 2010-12-21 2014-04-29 Boehringer Ingelheim International Gmbh Triazolylphenyl sulfonamides as serine/threonine kinase inhibitors
US8889684B2 (en) 2011-02-02 2014-11-18 Boehringer Ingelheim International Gmbh Azaindolylphenyl sulfonamides as serine/threonine kinase inhibitors
ITTO20130356A1 (it) * 2013-05-03 2014-11-04 Uni Degli Studi Del Piemonte Orientale Ame Inibitori di nicotinamide fosforibosil transferasi, relative composizioni, prodotti ed usi
MX363708B (es) 2013-10-14 2019-03-29 Eisai R&D Man Co Ltd Compuestos de quinolina selectivamente sustituidos.
SG10201704327RA (en) 2013-10-14 2017-06-29 Eisai R&D Man Co Ltd Selectively substituted quinoline compounds
CN116057045A (zh) 2020-06-05 2023-05-02 金耐特生物制药公司 成纤维细胞生长因子受体激酶抑制剂
WO2022188792A1 (zh) * 2021-03-12 2022-09-15 四川科伦博泰生物医药股份有限公司 具有蛋白激酶抑制活性的杂环化合物、包含其的药物组合物及其制备方法和用途
CN118340765B (zh) * 2024-04-30 2024-08-23 广州市朝利良生物科技有限公司 苯甲酰胺类化合物在制备促伤口愈合药物中的应用

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU507066B1 (en) 1977-09-06 1980-01-31 Sumitomo Chemical Company, Limited 2-Substituted-5-Hydroxy-1h-Imidazole 4-Carbozamide Derivatives
JPH03174153A (ja) 1989-09-20 1991-07-29 Fuji Photo Film Co Ltd カラー画像形成方法
CA2212061A1 (en) 1995-02-02 1996-08-08 Laramie Mary Gaster Indole derivatives as 5-ht receptor antagonist
AU6526896A (en) 1995-07-22 1997-02-18 Rhone-Poulenc Rorer Limited Substituted aromatic compounds and their pharmaceutical use
JP2003529536A (ja) 1999-02-09 2003-10-07 3−ディメンショナル ファーマシューティカルズ, インコーポレイテッド C1s介在疾患および状態の処置法、およびそれのための化合物および組成物
UA71971C2 (en) 1999-06-04 2005-01-17 Agoron Pharmaceuticals Inc Diaminothiazoles, composition based thereon, a method for modulation of protein kinases activity, a method for the treatment of diseases mediated by protein kinases
US6531478B2 (en) 2000-02-24 2003-03-11 Cheryl P. Kordik Amino pyrazole derivatives useful for the treatment of obesity and other disorders
US7199124B2 (en) 2001-02-02 2007-04-03 Takeda Pharmaceutical Company Limited JNK inhibitor
WO2003037274A2 (en) 2001-11-01 2003-05-08 Icagen, Inc. Pyrazole-amides and-sulfonamides
US20040010027A1 (en) 2001-12-17 2004-01-15 Pharmacia & Upjohn Spa Hydroxphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical comositions comprising them
JP2005162612A (ja) 2002-01-09 2005-06-23 Ajinomoto Co Inc アシルスルホンアミド誘導体
US7166628B2 (en) 2002-11-27 2007-01-23 Boehringer Ingelheim Pharmaceuticals, Inc. Cytokine inhibitors
CN102060806A (zh) 2003-09-11 2011-05-18 iTherX药品公司 细胞因子抑制剂
EP1663953A1 (en) 2003-09-24 2006-06-07 Methylgene, Inc. Inhibitors of histone deacetylase
WO2005040152A1 (en) 2003-10-20 2005-05-06 E.I. Dupont De Nemours And Company Heteroyclylphenyl-and heterocyclylpyridyl-substituted azolecarboxamides as herbicides
US7511042B2 (en) 2003-12-03 2009-03-31 Boehringer Ingelheim Pharmaceuticals, Inc. Triazole compounds
SI1725544T1 (sl) 2004-03-09 2009-10-31 Boehringer Ingelheim Pharma 3-(4-heterociklil-1,2,3-triazol-1-il)-N-aril-benzamidi kot inhibitorji proizvodnje citokinov za zdravljenje kroničnih vnetnih bolezni
US7485657B2 (en) 2004-05-12 2009-02-03 Boehringer Ingelheim Pharmaceuticals, Inc. Anti-cytokine heterocyclic compounds
US7531560B2 (en) 2004-11-10 2009-05-12 Boehringer Ingelheim Pharmaceuticals, Inc. Anti-cytokine heterocyclic compounds
EP1819341A4 (en) 2004-11-10 2011-06-29 Synta Pharmaceuticals Corp IL-12 MODULATORY CONNECTIONS
JP2007076376A (ja) 2005-09-09 2007-03-29 Yanmar Co Ltd トラクタ
WO2007056016A2 (en) 2005-11-02 2007-05-18 Kemia, Inc. Bisamide cytokine inhibitors
WO2007075896A2 (en) 2005-12-22 2007-07-05 Kemia, Inc. Heterocyclic cytokine inhibitors
JP2009536618A (ja) 2006-04-18 2009-10-15 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 4−及び5−イミダゾリル環を含むサイトカイン阻害化合物の製造方法及びその中間体
PE20120006A1 (es) 2006-05-15 2012-02-02 Boehringer Ingelheim Int Compuestos derivados de pirimidina como inhibidores de la quinasa aurora
BRPI0712795A2 (pt) 2006-07-07 2012-09-04 Boehringer Ingelheim Int derivados de heteroarila substituìdos com fenila e uso dos mesmos como agentes antitumorais
PT2041138E (pt) 2006-07-07 2014-10-07 Bristol Myers Squibb Co Inibidores de pirrolotriazina quinase
US8030487B2 (en) 2006-07-07 2011-10-04 Targegen, Inc. 2-amino—5-substituted pyrimidine inhibitors
RU2009103999A (ru) 2006-07-07 2010-08-20 Шеринг Корпорейшн (US) 3,4-дизамещенные циклобутен-1,2-дионы как лиганды схс-хемокиновых рецепторов
PE20080906A1 (es) 2006-08-17 2008-07-05 Kemia Inc Derivados heteroarilo como inhibidores de citocina
WO2008079909A1 (en) 2006-12-21 2008-07-03 Plexxikon, Inc. Pyrrolo [2,3-b] pyridines as kinase modulators
WO2008089034A2 (en) 2007-01-11 2008-07-24 Kemia, Inc. Cytokine inhibitors
EA019951B1 (ru) 2007-03-01 2014-07-30 Новартис Аг Ингибиторы киназы pim и способы их применения
PE20090837A1 (es) 2007-07-02 2009-07-24 Boehringer Ingelheim Int Nuevos compuestos quimicos
EP2176249A2 (en) 2007-07-02 2010-04-21 Boehringer Ingelheim International GmbH New chemical compounds
EP2170830B1 (en) 2007-07-17 2014-10-15 Plexxikon, Inc. 2-FLUORO-BENZENESULFONAMIDE COMPOUNDS AS Raf KINASE MODULATORS
JP5385382B2 (ja) 2008-07-24 2014-01-08 ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ プロテインキナーゼ阻害剤としての3,4−ジアリールピラゾール
TW201014860A (en) 2008-09-08 2010-04-16 Boehringer Ingelheim Int New chemical compounds
EA201100564A1 (ru) 2008-09-29 2011-12-30 Бёрингер Ингельхайм Интернациональ Гмбх Антипролиферативные соединения
US8569316B2 (en) 2009-02-17 2013-10-29 Boehringer Ingelheim International Gmbh Pyrimido [5,4-D] pyrimidine derivatives for the inhibition of tyrosine kinases
JP5871896B2 (ja) 2010-03-26 2016-03-01 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング B−rafキナーゼインヒビター
WO2011117382A1 (en) 2010-03-26 2011-09-29 Boehringer Ingelheim International Gmbh Pyridyltriazoles
US8710055B2 (en) 2010-12-21 2014-04-29 Boehringer Ingelheim International Gmbh Triazolylphenyl sulfonamides as serine/threonine kinase inhibitors
US20130023531A1 (en) 2011-01-27 2013-01-24 Boehringer Ingelheim International Gmbh Pyrimido[5,4-d]pyrimidylamino phenyl sulfonamides as serine/threonine kinase inhibitors
US8889684B2 (en) 2011-02-02 2014-11-18 Boehringer Ingelheim International Gmbh Azaindolylphenyl sulfonamides as serine/threonine kinase inhibitors

Similar Documents

Publication Publication Date Title
JP2014500296A5 (enExample)
JP2014504622A5 (enExample)
JP2013523614A5 (enExample)
JP2014500295A5 (enExample)
JP2017510610A5 (enExample)
JP2017527532A5 (enExample)
JP2017524025A5 (enExample)
JP2017523169A5 (enExample)
JP2017514809A5 (enExample)
JP2013532652A5 (enExample)
JP2019501125A5 (enExample)
JP2013512903A5 (enExample)
JP2009504763A5 (enExample)
JP2015522650A5 (enExample)
JP2017511360A5 (enExample)
JP2015531366A5 (enExample)
JP2008505157A5 (enExample)
JP2016531121A5 (enExample)
JP2014525420A5 (enExample)
JP2015527387A5 (enExample)
JP2014531449A5 (enExample)
JP2013525333A5 (enExample)
JP2019504050A5 (enExample)
JP2015536947A5 (enExample)
FI3546462T3 (fi) Uusi oksoisokinoliinijohdannainen